Last Updated: May 20, 2026

Claims for Patent: 9,212,357


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,212,357
Title:Thrombin solution and methods of use thereof
Abstract:Provided are methods for lyophilization of an aqueous thrombin solution, thrombin solutions for use in such lyophilization methods, and solid thrombin compositions produced by such methods.
Inventor(s):Roberto Meidler, Oleg Belyaev, Liliana Bar, Israel Nur
Assignee: Omrix Biopharmaceuticals Ltd
Application Number:US13/783,592

Details for Patent 9,212,357

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Omrix Biopharmaceuticals Ltd EVITHROM thrombin, topical (human) Solution 125247 August 27, 2007 ⤷  Start Trial 2033-03-04
Omrix Biopharmaceuticals Ltd EVITHROM thrombin, topical (human) For Injection 125247 September 17, 2009 ⤷  Start Trial 2033-03-04
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 9,212,357

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2014087394 ⤷  Start Trial
United States of America 2024376459 ⤷  Start Trial
United States of America 2022098570 ⤷  Start Trial
United States of America 2020032239 ⤷  Start Trial
United States of America 2016060614 ⤷  Start Trial
United States of America 2014154773 ⤷  Start Trial
United States of America 11993797 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.